What we might expect in hereditary angioedema with C1 inhibitor deficiency treatment?

Abstract

Hereditary angioedema with C1 inhibitor deficiency is rare disease with autosomal dominant inheritance pattern, incurable due to current knowledge base. There are many new drugs registered for treating this diagnosis, but many others are still in development.

Causal treatment which would correct C1 inhibitor deficiency might be a chance to treat this disease in the future.

Keywords

• hereditary angioedema
• C1 inhibitor
• bradykinin
• kallikrein
• transplantation
• gene therapy